Evidence map›Paper›PMID 36817146›Full record

ArticleFrontiers in pharmacology2023

Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba

Akimasa Iijima, Olga Švecová, Jan Hošek, Roman Kula, Markéta Bébarová

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The network of cardiac KNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  3. Chronic Propafenone Application Increases Functional KPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Akimasa IijimaDepartment of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Olga ŠvecováDepartment of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Jan HošekDepartment of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic.
Roman KulaDepartment of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Markéta BébarováDepartment of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Masaryk University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sildenafil (Viagra), the first approved and widely used oral drug for the treatment of erectile dysfunction, was occasionally associated with life-threatening ventricular arrhythmias in patients. Since inward rectifier potassium current (

Indexed as

arrhythmiabariuminward rectifierKir2.1Kir2.2sildenafil

Identifiers

PMID36817146
PMCPMC9932908
OpenAlexW4318997112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.